Classify Rx for pharmacology

The best revision companion

Veröffentlicht von: Nishith Sekhar Revappala

Beschreibung

A must have app for all medical and paramedical students.
"Hands down the best app for simple, quick and concise review of real Pharmacology"
Dr. Aeloj Shrestha
"Brilliant and must have app for medical students"
Sadat Mudassir
"Perfect Revision App"
Dhruvish Kapadia
“Drugs are the cornerstone of modern therapeutics”
-Harrison’s Principles of Internal Medicine
Pharmacology is the most important subject for building a strong career in modern healthcare. Pharmacology is one of the most difficult subject to go through in medical as well as other paramedical fields. It is considered to be the most volatile subject.
Classify Rx is the must have crisp pharmacology review app. It gives the classification of all the drugs in a simple format. Description of all the drugs and topics are also included.
The app is suitable for all medical students and healthcare professionals who are preparing for pharmacology examinations. Also helpful for professionals to brush up their pharmacology knowledge on the go.
Disclaimer: The app is not designed for providing prescription services. The data is provided solely for educational purpose of undergraduates for pharmacology preparation. We are not liable to any losses occurring from such use.
We strongly advice all healthcare professionals to go through appropriate product literature approved from relevant regulatory authorities before prescribing.
Features included:
Complete classification by system
Description of all drugs and topics
100+ illustrations
Search through drugs and topics
Mnemonics
Bookmark difficult topics
Completely offline mode - use it on the go
Regular latest updates
Ausblenden Mehr anzeigen...

Screenshots

Classify Rx for pharmacology Häufige Fragen

  • Ist Classify Rx for pharmacology kostenlos?

    Classify Rx for pharmacology ist nicht kostenlos (es kostet 69.90), enthält jedoch keine In-App-Käufe oder Abonnements.

  • Ist Classify Rx for pharmacology seriös?

    Nicht genügend Bewertungen, um eine zuverlässige Einschätzung vorzunehmen. Die App benötigt mehr Nutzerfeedback.

    Danke für die Stimme

  • Wie viel kostet Classify Rx for pharmacology?

    Der Preis von Classify Rx for pharmacology beträgt 69.90.

  • Wie hoch ist der Umsatz von Classify Rx for pharmacology?

    Um geschätzte Einnahmen der Classify Rx for pharmacology-App und weitere AppStore-Einblicke zu erhalten, können Sie sich bei der AppTail Mobile Analytics Platform anmelden.

Benutzerbewertung
Die App ist in Peru noch nicht bewertet.
Bewertungsverlauf

Classify Rx for pharmacology Bewertungen

Keine Bewertungen in Peru
Die App hat noch keine Bewertungen in Peru.

Store-Rankings

Ranking-Verlauf
Kategorien-Rankings
Diagramm
Kategorie
Rang
Top Bezahlt
7
Top Bezahlt
19
Top Umsatz
27
Top Bezahlt
39
Top Bezahlt
39

Classify Rx for pharmacology Konkurrenten

Name
Pyrls
Clinical Pearls
First Aid Cases - USMLE Step 1
400 high yield cases, 4th Ed.
Airway Triage
Self-Care Med
Your Health,Your Care,Yourself
InpharmD
Cardiac Trials
Sharim's Cardiac Trials
Pocket Spectrum - Antibiotics
STATworkUP® DDx Clinical Guide
Medical Differential Diagnosis
NAPLEX Practice Questions 2024
Pass NAPLEX Exam with us!
ApoThera
Clinical Decision Support

Classify Rx for pharmacology Installationen

Letzte 30 Tage

Classify Rx for pharmacology Umsatz

Letzte 30 Tage

Classify Rx for pharmacology Einnahmen und Downloads

Gewinnen Sie wertvolle Einblicke in die Leistung von Classify Rx for pharmacology mit unserer Analytik.
Melden Sie sich jetzt an, um Zugriff auf Downloads, Einnahmen und mehr zu erhalten.
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.